欣賀股份(003016.SZ)近期將推出抗菌、抑菌、抗病毒功能性面料服飾
格隆匯2月19日丨欣賀股份(003016.SZ)公佈,公司於近日收到福建省纖維檢驗中心出具的《檢測報吿》,報吿編號【W23002239-1】,檢測項目:抑菌、抗病毒活性。抗菌率(%):白色念珠菌83%;大腸桿菌96%;金黃色葡萄球菌96%。抗病毒活性率(%):甲型流感病毒H3N2(ATCCVR-1679)99.76%。
公司深耕中高端女裝領域30餘年,專注於國內中高端女裝的設計、生產和銷售,公司推出具備上述功能的產品計劃於近期上市,將進一步豐富公司產品的品類,對公司拓展市場產生積極的影響。公司計劃前期先小批量生產並銷售,後期根據市場反饋情況再決定是否擴大生產。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.